Xilio Therapeutics, Inc.XLONASDAQ
Loading
Total Assets Over TimeStable
Percentile Rank60
3Y CAGR-31.5%
5Y CAGR+2.5%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-31.5%/yr
Annual compound
5Y CAGR
+2.5%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2024$71.08M+16.7%
2023$60.93M-56.2%
2022$139.16M-37.2%
2021$221.60M+510.2%
2020$36.32M-42.1%
2019$62.72M-